Purpose Artificial Intelligence (AI) is increasingly being applied in the field of audiology, demonstrating potential to support screening, diagnosis, and rehabilitation in auditory and vestibular disorders. However, its effectiveness in guiding complex therapeutic decisions—such as those for idiopathic sudden sensorineural hearing loss (ISSNHL)–remains uncertain. This study aimed to compare treatment recommendations for ISSNHL made by medical doctors (MDs) with those proposed by an AI system (ChatGPT, GPT-4o model). The goal was to evaluate the concordance between human and AI decision-making, particularly regarding the administration of corticosteroids and adjunctive therapies, and to assess AI’s potential in clinical practice. Methods This study is a retrospective observational analysis. Data from 86 patients diagnosed with ISSNHL were retrospectively analysed. Treatment decisions by MDs were compared with those generated by ChatGPT using anonymized patient datasets and a series of sequential prompts simulating multidisciplinary discussion. Agreement between AI and MDs was assessed using Cohen’s Kappa coefficient. Results Overall, poor to fair agreement was observed between AI and clinician treatment decisions. ChatGPT did not recommend oral corticosteroids in 26 cases where MDs prescribed them (Kappa = 0.029) and recommended intravenous corticosteroids in 20 patients who were not treated with this approach by MDs (Kappa = 0.393). Discrepancies were also evident in recommendations for intratympanic steroids (Kappa = −0.044) and adjunctive therapies (Kappa = 0.035). These differences likely stem from the AI’s rigid adherence to generalized treatment protocols and limited contextual understanding. Conclusion While ChatGPT (GPT-4o) shows promise in generating structured, protocol-driven suggestions, its clinical decision-making capabilities for ISSNHL remain inferior to those of experienced physicians. The AI’s lack of individualized reasoning and context sensitivity resulted in frequent discordance with physician-led care. Thus, AI should currently be viewed as a supportive tool in audiological practice, with its integration requiring careful oversight and further validation in real-world clinical environments.

Human versus AI in audiological practice: A comparative evaluation of ChatGPT and physician treatment decisions in idiopathic sudden sensorineural hearing loss / Caragli, V., Pellegrino, M., Pingani, L., Galeazzi, G.M., Soloperto, D., Genovese, E., De Filippis, C., Marioni, G., Franz, L.. - In: PLOS ONE. - ISSN 1932-6203. - 21:6(2026). [10.1371/journal.pone.0350549]

Human versus AI in audiological practice: A comparative evaluation of ChatGPT and physician treatment decisions in idiopathic sudden sensorineural hearing loss

Caragli, Valeria;Pellegrino, Michele;Pingani, Luca;Galeazzi, Gian Maria;Soloperto, Davide;Genovese, Elisabetta;
2026

Abstract

Purpose Artificial Intelligence (AI) is increasingly being applied in the field of audiology, demonstrating potential to support screening, diagnosis, and rehabilitation in auditory and vestibular disorders. However, its effectiveness in guiding complex therapeutic decisions—such as those for idiopathic sudden sensorineural hearing loss (ISSNHL)–remains uncertain. This study aimed to compare treatment recommendations for ISSNHL made by medical doctors (MDs) with those proposed by an AI system (ChatGPT, GPT-4o model). The goal was to evaluate the concordance between human and AI decision-making, particularly regarding the administration of corticosteroids and adjunctive therapies, and to assess AI’s potential in clinical practice. Methods This study is a retrospective observational analysis. Data from 86 patients diagnosed with ISSNHL were retrospectively analysed. Treatment decisions by MDs were compared with those generated by ChatGPT using anonymized patient datasets and a series of sequential prompts simulating multidisciplinary discussion. Agreement between AI and MDs was assessed using Cohen’s Kappa coefficient. Results Overall, poor to fair agreement was observed between AI and clinician treatment decisions. ChatGPT did not recommend oral corticosteroids in 26 cases where MDs prescribed them (Kappa = 0.029) and recommended intravenous corticosteroids in 20 patients who were not treated with this approach by MDs (Kappa = 0.393). Discrepancies were also evident in recommendations for intratympanic steroids (Kappa = −0.044) and adjunctive therapies (Kappa = 0.035). These differences likely stem from the AI’s rigid adherence to generalized treatment protocols and limited contextual understanding. Conclusion While ChatGPT (GPT-4o) shows promise in generating structured, protocol-driven suggestions, its clinical decision-making capabilities for ISSNHL remain inferior to those of experienced physicians. The AI’s lack of individualized reasoning and context sensitivity resulted in frequent discordance with physician-led care. Thus, AI should currently be viewed as a supportive tool in audiological practice, with its integration requiring careful oversight and further validation in real-world clinical environments.
2026
21
Caragli, Valeria; Pellegrino, Michele; Pingani, Luca; Galeazzi, Gian Maria; Soloperto, Davide; Genovese, Elisabetta; De Filippis, Cosimo; Marioni, Gin...espandi
Human versus AI in audiological practice: A comparative evaluation of ChatGPT and physician treatment decisions in idiopathic sudden sensorineural hearing loss / Caragli, V., Pellegrino, M., Pingani, L., Galeazzi, G.M., Soloperto, D., Genovese, E., De Filippis, C., Marioni, G., Franz, L.. - In: PLOS ONE. - ISSN 1932-6203. - 21:6(2026). [10.1371/journal.pone.0350549]
File in questo prodotto:
File Dimensione Formato  
journal.pone.0350549 (1).pdf

Open access

Tipologia: VOR - Versione pubblicata dall'editore
Licenza: [IR] creative-commons
Dimensione 261.03 kB
Formato Adobe PDF
261.03 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1410388
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact